These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interactions of prostanoids with the platelet activating factors. Mentz P, Mentz G, Giessler C, Mest HJ. Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731 [Abstract] [Full Text] [Related]
6. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W, McNicholl IK, Choy PC, Man RY. Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [Abstract] [Full Text] [Related]
8. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. Sibelius U, Grandel U, Buerke M, Mueller D, Kiss L, Kraemer HJ, Braun-Dullaeus R, Haberbosch W, Seeger W, Grimminger F. Circulation; 1993 Oct; 101(1):78-85. PubMed ID: 10618308 [Abstract] [Full Text] [Related]
9. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart. Hu WM, Choy PC, Man RY. Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514 [Abstract] [Full Text] [Related]
10. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins. Giembycz MA, Kroegel C, Barnes PJ. J Immunol; 1990 May 01; 144(9):3489-97. PubMed ID: 2158510 [Abstract] [Full Text] [Related]
14. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2. Rizzo A, Taylor AE, Townsley MI, Logsdon P, Khimenko PL, Fletcher JR. Am J Physiol; 1995 May 01; 268(5 Pt 2):H1954-8. PubMed ID: 7771545 [Abstract] [Full Text] [Related]
16. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart. Hu WM, Man RY. Br J Pharmacol; 1991 Dec 01; 104(4):933-7. PubMed ID: 1810604 [Abstract] [Full Text] [Related]
17. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M, Lefort J, Malanchère E, Vargaftig BB. Eur J Pharmacol; 1987 Aug 21; 140(3):311-21. PubMed ID: 3653247 [Abstract] [Full Text] [Related]
18. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Ezra D, Laurindo FR, Czaja JF, Snyder F, Goldstein RE, Feuerstein G. Prostaglandins; 1987 Jul 21; 34(1):41-57. PubMed ID: 3685397 [Abstract] [Full Text] [Related]
19. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. Felix SB, Baumann G, Hashemi T, Niemczyk M, Ahmad Z, Berdel WE. J Cardiovasc Pharmacol; 1990 Jun 21; 15(6):987-97. PubMed ID: 1694923 [Abstract] [Full Text] [Related]
20. Endothelium-dependent effects of platelet-activating factor in the coronary circulation. Sagach VF, Zhukova AV, Braquet P. J Cardiovasc Pharmacol; 1992 Jun 21; 20 Suppl 12():S85-9. PubMed ID: 1282996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]